CPM
ELV icon

Chesapeake Partners Management’s Elevance Health ELV Stock Holding History

Chesapeake Partners Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$3.55M Sell
27,000
-212,980
-89% -$29.1M 0.53% 30
2016
Q1 		$33.4M Sell
239,980
-80,000
-25% -$10.7M 2.6% 16
2015
Q4 		$44.6M Buy
319,980
+236,826
+285% +$32.6M 2.5% 8
2015
Q3 		$11.6M Buy
+83,154
New +$12.5M 0.61% 62

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Chesapeake Partners Management's ELV Position: Q2 2016 in Review

Chesapeake Partners Management reduced its Elevance Health (ELV) stake by 89% in Q2 2016, selling an estimated $29.1M and leaving 27,000 shares worth $3.55M. The position accounts for 0.53% of the portfolio, ranked #30.

Chesapeake Partners Management first reported a position in ELV in Q3 2015 and has held it in 4 quarters since. The position peaked at $44.6M in Q4 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • Chesapeake Partners Management held 27,000 shares of Elevance Health worth $3.55M as of Q2 2016.
  • Chesapeake Partners Management sold 212,980 Elevance Health shares in Q2 2016, an estimated $29.1M.
  • Elevance Health made up 0.53% of Chesapeake Partners Management's portfolio in Q2 2016, its #30 holding.
  • Chesapeake Partners Management first reported a position in Elevance Health in Q3 2015 and has held it in 4 quarters since.
  • Chesapeake Partners Management's Elevance Health position peaked at $44.6M in Q4 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Chesapeake Partners Management's 13F filing for Q2 2016, filed 15 Aug 2016.